Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-041072
Filing Date
2025-05-08
Accepted
2025-05-08 16:15:57
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0239166-10q_inmune.htm   iXBRL 10-Q 464125
2 CERTIFICATION ea023916601ex31-1_inmune.htm EX-31.1 10304
3 CERTIFICATION ea023916601ex31-2_inmune.htm EX-31.2 10350
4 CERTIFICATION ea023916601ex32-1_inmune.htm EX-32.1 4088
5 CERTIFICATION ea023916601ex32-2_inmune.htm EX-32.2 4082
6 GRAPHIC image_001.jpg GRAPHIC 20948
7 GRAPHIC image_002.jpg GRAPHIC 11429
  Complete submission text file 0001213900-25-041072.txt   3659121

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE inmb-20250331.xsd EX-101.SCH 34779
9 XBRL CALCULATION FILE inmb-20250331_cal.xml EX-101.CAL 27000
10 XBRL DEFINITION FILE inmb-20250331_def.xml EX-101.DEF 165770
11 XBRL LABEL FILE inmb-20250331_lab.xml EX-101.LAB 319069
12 XBRL PRESENTATION FILE inmb-20250331_pre.xml EX-101.PRE 179126
65 EXTRACTED XBRL INSTANCE DOCUMENT ea0239166-10q_inmune_htm.xml XML 301029
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 25926351
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)